GlassScriptPhysician profile
David A Farcy
NPI 1760401186
$530.07
in general payments reported to CMS, 2019-2025
10 companies · $168 in 2025
The $168 reported for 2025 was more than what 78% of Emergency Medicine providers received nationally (typical 2025 total: $57.10).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $42.30 · 2020: $44.01 · 2021: $45.26 · 2022: $34.11 · 2023: $93.76 · 2024: $102 · 2025: $168.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $364.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $364.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Heartflow, INC. | $148.26 | 2025 | |
| Gilead Sciences, INC. | $85.97 | 2023-2024 | |
| Pfizer INC. | $75.75 | 2021-2025 | |
| Coloplast Corp | $50.01 | 2023 | Self-Cath |
| Allergan, INC. | $39.60 | 2019-2020 | |
| E.R. Squibb & Sons, L.L.C. | $32.03 | 2019-2024 | Eliquis |
| Ge Healthcare | $31.80 | 2020 | |
| Biosense Webster, INC. | $24.45 | 2023 | Carto 3 |
| Vapotherm INC | $23.81 | 2021 | |
| Abbvie INC. | $18.39 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Farcy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.